Integrative Signaling by Minimal Erythropoietin Receptor Forms and c-Kit*
暂无分享,去创建一个
[1] R. Gregory,et al. Subtraction cloning and initial characterization of novel epo-immediate response genes. , 2000, Cytokine.
[2] X. W. Wang,et al. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin , 2000, British Journal of Cancer.
[3] D. Waxman,et al. SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.
[4] L. Mei,et al. Neuregulin‐Increased Expression of Acetylcholine Receptorε‐Subunit Gene Requires ErbB Interaction with Shc , 1999 .
[5] R. Gregory,et al. Signal transduction in the erythropoietin receptor system. , 1999, Experimental cell research.
[6] D. Wojchowski,et al. A minimal cytoplasmic subdomain of the erythropoietin receptor mediates erythroid and megakaryocytic cell development. , 1999, Blood.
[7] H. Pendeville,et al. SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis , 1999, Cell.
[8] A. Mui,et al. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.
[9] F. Prósper,et al. Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines* , 1999, The Journal of Biological Chemistry.
[10] H. Lodish,et al. Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.
[11] J. Johnston,et al. Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[12] A. Miyajima,et al. Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retrovirus-mediated expression. , 1999, Blood.
[13] K. Okkenhaug,et al. Socs1 binds to multiple signalling proteins and suppresses Steel factor‐dependent proliferation , 1999, The EMBO journal.
[14] I. Wilson,et al. Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.
[15] H. Varmus,et al. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. , 1998, Genes & development.
[16] M. Zenke,et al. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. , 1998, Blood.
[17] J. Cleveland,et al. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. , 1998, Genes & development.
[18] Z. Zhao,et al. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis , 1998 .
[19] D. Seshasayee,et al. GATA-1 Dominantly Activates a Program of Erythroid Gene Expression in Factor-Dependent Myeloid FDCW2 Cells , 1998, Molecular and Cellular Biology.
[20] Michael P. Brown,et al. Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.
[21] J. Kuźnicki,et al. Molecular Cloning and Expression of a Mouse Brain cDNA Encoding a Novel Protein Target of Calcyclin , 1998, Journal of neurochemistry.
[22] J. Marine,et al. Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.
[23] J L Cleveland,et al. Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. , 1998, Genes & development.
[24] J. Gustafsson,et al. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2 , 1998, Molecular and Cellular Endocrinology.
[25] E. Price,et al. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes , 1998, Nature.
[26] D. Seshasayee,et al. Mechanisms of stem cell factor and erythropoietin proliferative co-signaling in FDC2-ER cells. , 1997, Blood.
[27] H. Sakamoto,et al. Cloning and characterization of novel CIS family genes. , 1997, Biochemical and biophysical research communications.
[28] A. Kahn,et al. Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. , 1997, Blood.
[29] V. Broudy,et al. Stem cell factor and hematopoiesis. , 1997, Blood.
[30] M. Bondurant,et al. The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. , 1997, Blood.
[31] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[32] S. Akira,et al. Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.
[33] Takaho A. Endo,et al. A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.
[34] H. Lodish,et al. The Prolactin Receptor and Severely Truncated Erythropoietin Receptors Support Differentiation of Erythroid Progenitors* , 1997, The Journal of Biological Chemistry.
[35] A. Yoshimura,et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.
[36] D. Wojchowski,et al. Mitogenic Signaling and Inhibition of Apoptosis via the Erythropoietin Receptor Box-1 Domain* , 1997, The Journal of Biological Chemistry.
[37] T. Ley,et al. Molecular Cloning, Chromosomal Localization, and Expression of Murine Dipeptidyl Peptidase I* , 1997, The Journal of Biological Chemistry.
[38] J. Hoidal,et al. Human Dipeptidyl-peptidase I , 1997, The Journal of Biological Chemistry.
[39] H. Lodish,et al. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[40] P. Dentelli,et al. Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation. , 1996, Oncogene.
[41] Y. Yamauchi,et al. Improved dicistronic mRNA expression vectors for efficient selection of transfectants highly expressing foreign genes. , 1996, BioTechniques.
[42] J. Ihle,et al. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response , 1996, Molecular and cellular biology.
[43] J. Krosl,et al. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin‐induced cell proliferation and Stat5 activation. , 1995, The EMBO journal.
[44] Rudolf Jaenisch,et al. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.
[45] E. Jost,et al. Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. , 1995, Experimental cell research.
[46] E. Petricoin,et al. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. , 1995, Science.
[47] H. Lodish,et al. Interaction of the erythropoietin and stem-cell-factor receptors , 1995, Nature.
[48] I. Dusanter-Fourt,et al. Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction. , 1995, Blood.
[49] Ursula Klingmüller,et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.
[50] A. Hata,et al. Tyrosine kinases Lyn and Syk regulate B cell receptor‐coupled Ca2+ mobilization through distinct pathways. , 1994, The EMBO journal.
[51] E. Prochownik,et al. Differential patterns of DNA binding by myc and max proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[52] D. Quelle,et al. Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Berns,et al. The pim‐1 oncogene encodes two related protein‐serine/threonine kinases by alternative initiation at AUG and CUG. , 1991, The EMBO journal.
[54] J. Ihle,et al. Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line. , 1982, Journal of immunology.
[55] M. Loeffler,et al. Effects of continuous stem cell factor administration on normal and erythropoietin‐stimulated murine hemopoiesis: Experimental results and model analysis , 1995, Stem cells.